According to United Therapeutics's latest financial reports the company's current EPS (TTM) is $18.87. In 2022 the company made an earnings per share (EPS) of $16.01 an increase over its 2021 EPS that were of $10.59.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $18.87 | 17.86% |
2022 | $16.01 | 51.18% |
2021 | $10.59 | -9.1% |
2020 | $11.65 | -581.4% |
2019 | -$2.42 | -117.79% |
2018 | $13.60 | 42.11% |
2017 | $9.57 | -40.93% |
2016 | $16.20 | 13.45% |
2015 | $14.28 | 104.29% |
2014 | $6.99 | 100.29% |
2013 | $3.49 | -40.34% |
2012 | $5.85 | 53.95% |
2011 | $3.80 | 102.13% |
2010 | $1.88 | 415.07% |
2009 | $0.37 | -136.87% |
2008 | -$0.99 | -310.64% |
2007 | $0.47 | -70.81% |
2006 | $1.61 | 12.98% |
2005 | $1.42 | 307.14% |
2004 | $0.35 | -252.17% |
2003 | -$0.23 | -60% |
2002 | -$0.58 | -37.5% |
2001 | -$0.92 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $3.82 | -79.76% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $7.10 | -62.38% | ๐บ๐ธ USA |
![]() Baxter BAX | -$5.66 | -129.99% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $4.39 | -76.74% | ๐บ๐ธ USA |
![]() Cardinal Health CAH | $1.01 | -94.65% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $8.34 | -55.82% | ๐ฌ๐ง UK |
![]() Cytokinetics
CYTK | -$5.69 | -130.15% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | -$2.00 | -110.60% | ๐ฎ๐ฑ Israel |